SCHEMBL6000698

SCHEMBL6000698

OC(CCCc1ccccc1)c1nnn[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.41
GRIK1 P39086 1/20 0.38
CES1 P23141 1/20 0.38
NCEH1 Q6PIU2 1/20 0.38
ADRB2 P07550 2/20 0.37
TRPA1 O75762 1/20 0.37
HDAC3 O15379 1/20 0.37
MAPK1 P28482 1/20 0.37
ADRA1A P35348 1/20 0.37
HDAC4 P56524 1/20 0.37
SLC6A3 Q01959 1/20 0.37
HDAC1 Q13547 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6002903 0.95 FAAH (0.46) FAAHCES1NCEH1TRPA1
SCHEMBL6002777 0.94 FAAH (0.48) FAAHCES1NCEH1TRPA1
SCHEMBL19354535 0.83 IDO1 (0.43) TRPA1
SCHEMBL19354261 0.83 IDO1 (0.43) TRPA1
SCHEMBL2093740 0.83 DAO (0.38) GRIK1CES1NCEH1HDAC3MAPK1
SCHEMBL5645337 0.80 MAOA (0.40) GRIK1SLC6A3SMN1; SMN2
SCHEMBL9462841 0.79 CYP19A1 (0.38) FAAHGRIK1CES1NCEH1
SCHEMBL2097333 0.78 CES1 (0.39) FAAHCES1NCEH1TRPA1
SCHEMBL2096342 0.77 CES1 (0.41) FAAHCES1NCEH1TRPA1
SCHEMBL2095618 0.77 CES1 (0.41) FAAHCES1NCEH1TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed